This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DNA Microarray 2013: A Focus On Sales Growth

Figure 8.7 Top ten reasons for using DNA microarray in the Government organisations, indicated by individuals who participated in Microarray 2012

Figure 8.8 Top ten reasons for using DNA microarray in the healthcare industry, indicated by individuals who participated in Microarray 2012

Figure 8.9 Top ten reasons for using DNA microarray in the pharmaceutical industry, indicated by individuals who participated in Microarray 2012

Figure 8.10 Top ten reasons for using DNA microarray in research institutes, indicated by individuals who participated in Microarray 2012

Figure 8.11 Top ten reasons for using DNA microarray in universities, indicated by individuals who participated in Microarray 2012  

Chapter 9 Samples

9.1 This Chapter9.2 Samples9.3 Discussion

Figure 9.1 Top ten sample types analysed using DNA microarray, indicated by individuals who participated in Microarray 2012

Table 9.1 Sample types analysed using DNA microarray, indicated by individuals who participated in Microarray 2012

Chapter 10 Sample Preparation

10.1 This Chapter

10.2 Sample Preparation

10.3 Discussion

Figure 10.1 Top sample preparation methods of DNA microarray users who participated in Microarray 2012

Table 10.1 Sample preparation methods of DNA microarray users who participated in Microarray 2012

Figure 10.2 Other sample preparation methods of DNA microarray users who participated in Microarray 2012

Table 10.2 Other sample preparation methods of DNA microarray users who participated in Microarray 2012

Chapter 11 Therapeutic Areas

11.1 This Chapter

11.2 Therapeutic Areas

11.3 Discussion

Figure 11.1 Top ten therapeutic areas of DNA microarray users who participated in Microarray 2012

Table 11.1 Therapeutic areas of DNA microarray users who participated in Microarray 2012

Figure 11.2 Other therapeutic areas of DNA microarray users who participated in Microarray 2012

Table 11.2 Other therapeutic areas of DNA microarray users who participated in Microarray 2012

Chapter 12 Disease Biomarkers

12.1 This Chapter

6 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,560.14 -82.87 -0.50%
S&P 500 1,977.40 -11.47 -0.58%
NASDAQ 4,803.0240 -25.3010 -0.52%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs